Evolution of locomotion disorders in Huntington's disease

被引:8
|
作者
Delval, A. [1 ]
Krystkowiak, P. [2 ]
Blatt, J. -L. [1 ]
Delliaux, M. [3 ]
Destee, A. [3 ]
Derambure, P. [1 ]
Defebvre, L. [3 ]
机构
[1] CHRU, Hop R Salengro, Serv Neurophysiol Clin, F-59037 Lille, France
[2] CHU Amiens, Hop Nord, Serv Neurol, F-80054 Amiens 1, France
[3] CHRU, Hop R Salengro, Serv Neurol & Pathol Mouvement, F-59037 Lille, France
来源
关键词
gait; gait initiation; anticipatory postural adjustments; Huntington's disease; decline;
D O I
10.1016/j.neucli.2008.01.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. - Locomotion disorders are important in Huntington's disease (HD). Although the rates of evolution of motor, functional or cognitive aspects of HD have been studied, the evolution of locomotion disorders in early stages of the disease remains unknown. Objectives. - To determine the rate of evolution of the HD-associated gait and gait initiation disorders and their correlates. Patients and methods. - Eighteen HD patients were recorded with a minimum interevaluation interval of one year. Akinesia was studied by evaluating the anticipatory postural adjustment (APA) phase preceding the first step. We also evaluated gait speed, stride time and stride length. Results. - We observed an alteration in the APA phase, whose evolution was correlated with that of akinesia. We also observed a decrease in gait speed, which was due both to an increase in stride time and a decrease in stride length. Stride-to-stride variability did not worsen between both evaluations. Conclusions. - A worsening in both gait initiation and gait performance was observed in HD. Initial weak functional capacity and more severe motor impairment seem to be associated with a faster progression of locomotion parameters in these mildly impaired HD patients. (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 50 条
  • [21] A FREQUENCY OF CONCOMITANT DISORDERS IN PRESYMPTOMATIC HUNTINGTON'S DISEASE PATIENTS
    Puch, Elzbieta Alicja
    Witkowski, Grzegorz
    Isalan, Mark
    Mielcarek, Michal
    Zielonka, Daniel
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A42 - A43
  • [22] Prevalence of psychiatric disorders in different stages of Huntington's disease
    Roos, R.
    VanDuyn, E.
    Zitman, F.
    Tibben, A.
    VanDerMast, R.
    MOVEMENT DISORDERS, 2006, 21 : S360 - S361
  • [23] Prevalence of psychiatric disorders in different stages of Huntington's disease
    van Duijn, E
    Zitman, FG
    Tibben, A
    Roos, RAC
    van der Mast, RC
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [24] Treatment of Apathy in Huntington’s Disease and Other Movement Disorders
    Ashok Krishnamoorthy
    David Craufurd
    Current Treatment Options in Neurology, 2011, 13 : 508 - 519
  • [25] Neuropsychiatry of Huntington's disease and other basal ganglia disorders
    Rosenblatt, A
    Leroi, I
    PSYCHOSOMATICS, 2000, 41 (01) : 24 - 30
  • [26] Circadian Rhythm, Cognition, and Mood Disorders in Huntington's Disease
    Bellosta Diago, Elena
    Martinez-Horta, Saul
    Santos Lasaosa, Sonia
    Viloria Alebesque, Alejandro
    Perez-Perez, Jesus
    Kulisevsky, Jaime
    Lopez del Val, Javier
    JOURNAL OF HUNTINGTONS DISEASE, 2018, 7 (02) : 193 - 198
  • [27] Concomitant disorders prevalence in Huntington's disease affected individuals
    Zielonka, D.
    Puch, E. A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1055 - 1056
  • [28] Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders
    Holmans, Peter A.
    Massey, Thomas H.
    Jones, Lesley
    HUMAN MOLECULAR GENETICS, 2017, 26 (R2) : R83 - R90
  • [30] Huntington's disease: Neuropsychiatric manifestations of Huntington's disease
    Goh, Anita M. Y.
    Wibawa, Pierre
    Loi, Samantha M.
    Walterfang, Mark
    Velakoulis, Dennis
    Looi, Jeffrey C. L.
    AUSTRALASIAN PSYCHIATRY, 2018, 26 (04) : 366 - 375